Berlin: The World Health Organization says it is ending a trial into whether anti-malaria drug hydroxychloroquine helps patients hospitalised with COVID-19.

WHO said Saturday it has accepted the recommendation from the committee overseeing the trial to discontinue testing of hydroxychloroquine and lopinavir/ritonavir, a drug combination used to treat HIV/AIDS. The drugs were being compared with standard care for hospitalized patients.

WHO says a review of the interim results showed hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care.

The agency adds that while there was no solid evidence of increased mortality for hospitalized patients given the drugs, there were some associated safety signals in the clinical laboratory findings of an associated trial.

WHO says the decision won't affect possible trials on patients who aren't hospitalized, or on those receiving the drugs before potential exposure to the coronavirus or shortly afterward.

Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.



New Delhi (PTI): Air India Group is looking to add capacity to help passengers impacted by the IndiGo flight disruptions.

"Since 4 December, economy class airfares on non-stop domestic flights have been proactively capped to prevent the usual demand-and-supply mechanism being applied by revenue management systems," a statement said on Saturday.

Both Air India and Air India Express have put in place caps on economy class fares.

ALSO READ: IndiGo cancels over 200 flights from Delhi, Mumbai on Saturday

The statement from Air India came hours after the government announced introduction of airfare caps amid IndiGo flight disruptions.

Air India also said it is not technically possible to cap fares for all flight permutations.

"Air India and Air India Express are seeking to add capacity to help travellers and their baggage reach their destinations as quickly as possible," the statement said.